共 16 条
[1]
Erkan D., Lockshin M., New treatments for antiphospholipid syndrome, Rheum Dis Clin N Am, 32, pp. 129-148, (2006)
[2]
Thomson C., Forbes C., Prentice R., The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo, Clin Sci Mol Med, 45, pp. 485-494, (1973)
[3]
Salzman E.W., Rosenberg R.D., Smith M.H., Et al., Effect of heparin and heparin fractions on platelet aggregation, J Clin Invest, 65, pp. 64-73, (1980)
[4]
Hirsh J., Drug therapyL Heparin, New Engl J Med, 324, pp. 1565-1574, (1991)
[5]
Annich G., Meinhardt J., Mowery K., Et al., Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers, Crit Care Med, 28, pp. 915-920, (2000)
[6]
Thakur M.L., Welch M.J., Joist J.H., Coleman R.E., Indium-111 labeled platelets: Studies on preparation and evaluation of in vitro and in vivo functions, Thromb Res, 9, pp. 345-357, (1976)
[7]
Rand M.L., Packham M.A., Mustard J.F., Survival of density subpopulations of rabbit platelets: Use of 51Cr- or 111In-labeled platelets to measure survival of least dense and most dense platelets concurrently, Blood, 61, pp. 362-367, (1983)
[8]
Ardlie N.G., Packham M.A., Mustard J.F., Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets, Br J Haematol, 19, pp. 7-17, (1970)
[9]
Timmons S., Hawiger J., Separation of human platelets from plasma proteins including Factor VIII by a combined albumin gradient-gel filtration method using HEPES buffer, Thromb Res, 56, pp. 1013-1019, (1978)
[10]
Day H.J., Rao A.K., Evaluation of platelet function, Semin Hematol, 23, pp. 89-101, (1986)

